[1] Lemmer A, VanWagner LB, Ganger D. Assessment of Advanced Liver Fibrosis and the Risk for Hepatic Decompensation in Patients With Congestive Hepatopathy. Hepatology. 2018;68:1633-1641.
[2] Evans WN, Acherman RJ, Ciccolo ML, et al. MELD-XI Scores Correlate with Post-Fontan Hepatic Biopsy Fibrosis Scores. Pediatr Cardiol. 2016 Oct;37(7):1274-1277.
[3] Dijkstra H, Wolff D, van Melle JP, et al. Diminished liver microperfusion in Fontan patients: A biexponential DWI study. PLoS One. 2017,12:e0173149.
[4] Nakatsuka T, Soroida Y, Nakagawa H, et al. Identification of liver fibrosis using the hepatic vein waveform in patients with Fontan circulation. Hepatol Res. 2018 Sep 4[Epub ahead of print].
[5] Myers RP, Cerini R, Sayegh R, et al. Cardiac hepatopathy: clinical, hemodynamic, and histologic characteristics and correlations. Hepatology. 2003 Feb;37(2):393-400.
[6] Elder RW, McCabe NM, Hebson C, et al. Features of portal hypertension are associated with major adverse events in Fontan patients: the VAST study. Int J Cardiol. 2013;168:3764-3769. |
